Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

FRA/8AT stock hub

FRA/8AT has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/8ATis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

585M

Frankfurt Stock Exchange

Market data

Price

Recent price action with selectable time range.

FRA/8ATFRA/8AT

—

Loading chart…

In the news

Latest news · FRA/8AT

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC-39

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/8AT market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

123

Groups with data

Currency

USD

Showing 123 of 123 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	71
Employees Change	9%
Employees Change Percent	14.06
Enterprise value	EUR 458.2M
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	EUR 585M
Price	EUR 4.1
Price currency	EUR
Rev Per Employee	102,207.03x
Sic	2834
Symbol	fra/8AT
Website	https://www.aclaristx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-10.33%
EV Earnings	-7.58x
EV/Sales	64.45x
P/B ratio	6.54x
P/S ratio	80.61x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	EUR -45M
Net Income	EUR -60.4M
Pretax Margin	-832.58%
Profit Per Employee	EUR -850,956
Roa5y	-23.63
Roe5y	-61.18
ROIC	-38.97

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	266.43%
Cagr3y	-29.76%
Cagr5y	-26.89%
Revenue Growth	-52.93x
Revenue Growth Q	37.18x
Revenue Growth3 Y	-35.25x
Revenue Growth5 Y	4.08x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	EUR 78.7M
Debt	EUR 1.8M
Debt Equity	EUR 0.02
Equity	EUR 89.4M
Net Cash	EUR 129.4M
Net Cash By Market Cap	EUR 22.13
Net Cash Growth	-20.63%
Net Debt Equity	EUR -1.45
Tangible Book Value	EUR 89.4M
Tangible Book Value Per Share	EUR 0.74

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-37.77%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	266.1%
200-day SMA	2.38
3Y total return	-65.35%
50-day SMA	3.24
50-day SMA vs 200-day SMA	50over200
5Y total return	-79.11%
All Time High	30.53
All Time High Change	-86.56%
All Time High Date	2017-04-18
All Time Low	0.59
All Time Low Change	595.59%
All Time Low Date	2023-11-13
ATR	0.11
Ch YTD	62.28
High	4.1
High52	4.1
High52 Date	2026-05-08
High52ch	0%
Low	4.1
Low52	1.04
Low52 Date	2025-05-15
Low52ch	295.38%
Ma50ch	26.55%
Price vs 200-day SMA	72.36%
RSI	69.39
RSI Monthly	56.28
RSI Weekly	70.16
Sharpe ratio	1.77x
Sortino ratio	3.33
Total Return	-37.77%
Tr YTD	62.28
Tr1m	25.81%
Tr1w	10.15%
Tr3m	44.36%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -68.1M
Operating margin	-938

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	96,690,016%
Shares Insiders	2.26%
Shares Institutions	44.09%
Shares Qo Q	5.01%
Shares Yo Y	37.77%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	132.05x
Bv Per Share	0.74
Ch1m	25.81
Ch1w	10.15
Ch1y	266.1
Ch3m	44.36
Ch3y	-65.35
Ch5y	-79.11
Ch6m	110.2
Change	1.74%
Change From Open	0
Close	4.03
Days Gap	1.74
Earnings Date	2026-05-14
EBIT	EUR -68.1M
EPS	EUR -0.49
F Score	0
Fiscal Year End	December
Founded	2,012
Is Primary Listing	0
Last Earnings Date	2026-02-27
Last Report Date	2026-03-31
Ma150	2.66
Ma150ch	54.23%
Ma20	3.63
Ma20ch	13%
Next Earnings Date	2026-05-14
Open	4.1
Price Date	2026-05-08
Ptbv Ratio	6.54
Relative Volume	1,586.09x
Revenue	7,256,699x
Tr6m	110.3%
Volume	0

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/8AT pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/8AT stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/8AT?

Insider, institutional, and short-interest positioning.

Institutional ownership

+44.1%

Share of float held by funds and institutions

Insider ownership

+2.3%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+37.8%

Negative means the company is buying back shares.

Technical

FRA/8AT momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

69.4

Neutral momentum band

Price vs 200-day MA

+72.4%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

1.77

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/8AT

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/8AT stock rating?

fra/8AT is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/8AT analysis?

The full report lives at /stocks/fra/8AT/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/8AT?

The latest report frames fra/8AT around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/8AT page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.